BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3095919)

  • 1. [The value of the guaiac test in the screening of colorectal tumors].
    de Peyer R
    Schweiz Med Wochenschr; 1986 Oct; 116(40):1381-4. PubMed ID: 3095919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening for colo-rectal neoplasms by the study of fecal occult blood].
    Castiglione G; Pacini F; Maltoni G
    Quad Sclavo Diagn; 1984 Dec; 20(4):440-50. PubMed ID: 6537553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for colorectal cancer: the rationale and a recent advance in the detection of fecal occult blood.
    Friend WG
    Prog Clin Biol Res; 1985; 186():65-76. PubMed ID: 4034607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adapted program of colorectal cancer screening--7 years experience and cost-benefit analysis.
    Fric P; Zavoral M; Dvoráková H; Zoubek V; Roth Z
    Hepatogastroenterology; 1994 Oct; 41(5):413-6. PubMed ID: 7851847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance and early diagnosis of colorectal cancer.
    Winawer SJ; Prorok P; Macrae F; Bralow SP
    Cancer Detect Prev; 1985; 8(3):373-92. PubMed ID: 3933835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for large bowel cancer.
    Barnes R
    Practitioner; 1989 May; 233(1468):691-4. PubMed ID: 2513566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening: new opportunities.
    Levin TR
    Surg Oncol Clin N Am; 1999 Oct; 8(4):673-91, vi-vii. PubMed ID: 10452934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia.
    Winawer SJ; Fleisher M
    Gastroenterology; 1982 May; 82(5 Pt 1):986-91. PubMed ID: 7060917
    [No Abstract]   [Full Text] [Related]  

  • 16. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
    Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
    Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The status of colon cancer screening].
    Fujiyoshi T
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2223-31. PubMed ID: 1929442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection--the priority in colorectal cancer.
    Messner RL; Gardner SS; Webb DD
    Cancer Nurs; 1986 Feb; 9(1):8-14. PubMed ID: 3085917
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mass screening for colorectal cancer--issues and future prospects].
    Kobayashi S
    Gan No Rinsho; 1984 May; 30(6 Suppl):611-5. PubMed ID: 6748232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.